Introduction
============

Familial renal glucosuria \[FRG; Online Mendelian Inheritance in Man (<https://www.omim.org>) no. 233100\] is a hereditary kidney disease characterized by persistent glucosuria due to a reduction in the renal tubular reuptake of glucose, along with normal blood glucose levels and no other impaired tubular functions ([@b1-mmr-19-05-4364]). In general, FRG is a benign condition that does not require any specific therapy. The ability of the kidney to reabsorb glucose principally involves the lower-affinity high-capacity sodium-glucose cotransporter 2 (SGLT2), which is located in the proximal convoluted tubule segment S1 and has a Na^+^-glucose coupling ratio of 1:1 ([@b2-mmr-19-05-4364]). SGLT2 is encoded by the solute carrier family 5 member 2 (*SLC5A2*) gene and has 672 amino acids. A large number of case reports conducted using patients of different ethnicities have confirmed that *SLC5A2* mutations are responsible for the majority of FRG cases ([@b3-mmr-19-05-4364]--[@b22-mmr-19-05-4364]). Variations in the *SLC5A2* gene impact the function of SGLT2, leading to isolated glucosuria. However, various different modes of inheritance have been reported for FRG. Notably, research on SGLT2 has been benefitted in recent years by its identification as a therapeutic target in type 2 diabetes mellitus. In the present study, an association between FRG and a novel compound heterozygous mutation of the *SLC5A2* gene was identified. Moreover, all the *SLC5A2* mutations in patients with FRG that have been reported to date are summarized in the present study. The present study provides additional information on the genetic mechanism of FRG.

Materials and methods
=====================

### Subject

The subject of the present study was a Han Chinese girl. The patient was observed to exhibit glucosuria in the absence of hyperglycemia at the age of 1 year and 9 months, following an initial urine test. Routine urinary analysis showed glucose in the range + (100 mg/dl) to +++ (500 mg/dl), with no other abnormalities. The quantitative test for urine glucose gave a result of 15.77 g/1.73 m^2^/24 h. The patient was subjected to an oral glucose tolerance test and exhibited a 2-h postprandial sugar level of 5.1 mmol/l. The patient had no polyuria, polydipsia or polyphagia, and her body weight gain was the same as that of age-matched children. The patient experienced no problems with activity, eating, sleeping or excretory function. There was no reported history of trauma or poisoning. The parents and other family members had no history of glucosuria.

### Genetic testing

Following collection of 2 ml blood samples from the parents of the patient, who had no history of FRG, and healthy controls from July to August 2017, genomic DNA was extracted from the peripheral blood leukocytes using a Wizard genomic DNA purification kit (Promega Corporation, Madison, WI, USA), according to the manufacturer\'s protocol. A total of fifty healthy controls (28 males and 22 females; average age 38.84±29.78 months) were recruited. Initially, 900 µl of cell lysis solution was added to a sterile 1.5 ml microcentrifuge tube with 300 µl collected blood to separate the leukocytes. All the exons and conterminal intronic regions of the *SLC5A2* gene were amplified via polymerase chain reaction (PCR) using a Thermal Cycler 9700 (Applied Biosystems; Thermo Fisher Scientific, Inc., Waltham, MA, USA). The primers (forward for Exon5, 5′-ACCACTGCGAGGGTTATGAT-3′ and reverse for Exon5, 5′-TCCTCACTCAAGCCCAGCAT-3′; forward for Exon12, 5′-GTGTTCATCGTGGTAGTGTCGG-3′ and reverse for Exon12, 5′-CCCTCAGTCGAGAAATTCAGG-3′) were designed using Primer Premier 5.0 software (Premier Biosoft International, Palo Alto, CA, USA). The PCRs were conducted in a total volume of 20 µl containing 1.6 µl DNA, 10 µl 2X Taq Master Mix (CWBIO, Beijing, China), 0.8 µl forward primer (Sangon Biotech Co., Ltd., Shanghai, China), 0.8 µl reverse primer (Sangon Biotech Co., Ltd.) and ddH~2~O (added to a final volume of 20 µl), with the following thermal cycling conditions: Denaturing at 94°C for 5 min, 35 cycles of denaturing at 94°C for 30 sec, annealing at 57°C for 30 sec and extension at 72°C for 30 sec, followed by extension at 72°C for 10 min. The sequence analysis of the two coding exons of the *SLC5A2* gene was performed using an ABI Prism 3130 genetic analyzer (Applied Biosystems; Thermo Fisher Scientific, Inc.). Potential mutations were defined by their exclusion from the Human Gene Mutation Database (<http://www.hgmd.cf.ac.uk>) and previously reported mutations on PubMed (<http://ncbi.nlm.nih.gov/PubMed/>). A total of fifty healthy Chinese individuals containing 100 chromosomes were included as controls. A total of three databases, the dbSNP database of the National Center for Biotechnology Information (<http://www.ncbi.nlm.nih.gov/snp/>), Exome Variant Server (<http://evs.gs.washington.edu/EVS>) and 1000 Genomes Project (<http://www.1000genomes.org/>), were used to eliminate single-nucleotide polymorphisms (SNPs). The study was approved by the Institutional Review Board of the Third Xiangya Hospital, Central South University (Changsha, China).

### Homology analysis

A comparative analysis of multiple amino acid sequences of SGLT2 was performed for different species using the Basic Local Alignment Search Tool (<https://blast.ncbi.nlm.nih.gov/Blast.cgi>). The aligned reference sequences were *Homo sapiens* (GenBank NP_003032.1), *Pan troglodytes* (XP_003315117.1), *Macaca mulatta* (XP_001113206.1), *Canis lupus* (XP_005621284.1), *Bos taurus* (NP_976236.1), *Mus musculus* (NP_573517.1), *Rattus norvegicus* (NP_072112.2), *Danio rerio* (NP_998091.1) and *Xenopus tropicalis* (XP_002940641.2).

### Pathogenicity prediction

The functional effects of protein variants were predicted using three online prediction tools, PolyPhen2 (<http://genetics.bwh.harvard.edu/pph2/>), SIFT (<http://sift.jcvi.org>) and Mutation Taster (<http://www.mutationtaster.org>). These online tools predict the pathogenicity of an altered protein based on the number of conserved amino acids and changes in protein structure.

### Literature review

All of the literature previously published on the *SLC5A2* mutations (between 2002 and 2017) was retrieved from PubMed. The mutation locations and types for the *SLC5A2* gene were summarized.

Results
=======

### Genetic testing of the SLC5A2 gene

According to the direct sequencing of the *SLC5A2* gene from the patient with FRG, a novel 1 bp missense mutation in exon 5 (c.514T\>C, p.W172R) and a previously reported 1 bp missense mutation in exon 12 (c.1540C\>T, p.P514S) were revealed ([Fig. 1A](#f1-mmr-19-05-4364){ref-type="fig"}). The father of the patient carried the same p.P514S mutation, while her mother had the same p.W172R mutation ([Fig. 1B and C](#f1-mmr-19-05-4364){ref-type="fig"}). However, neither of the parents exhibited glycosuria or hyperglycemia, with fasting plasma glucose levels of 4.8 and 3.9 mmol/l. Screening of the *SLC5A2* gene in healthy Chinese individuals revealed no mutant alleles in exon 5 or exon 12 among 100 screened chromosomes. The novel p.W172R mutation was not identified in the three SNP databases used in the present study.

### Functional prediction of the SLC5A2 mutations

The results of a comparative analysis of multiple amino acid sequences revealed that the p.W172R and p.P514S variants occurred in highly conserved locations. In addition, the amino acid residues adjacent to the p.W172R and p.P514S variants were also highly conserved among a number of species ([Fig. 2](#f2-mmr-19-05-4364){ref-type="fig"}). The results of the online analysis performed using PolyPhen-2, SIFT, and Mutation Taster demonstrated that the mutations p.W172R and p.P514S may be deleterious and may be associated with FRG ([Fig. 3](#f3-mmr-19-05-4364){ref-type="fig"}; [Table I](#tI-mmr-19-05-4364){ref-type="table"}).

### Results of the literature review

To date, 115 index cases of FRG, including the proband assessed in the present study, have been retrieved in total ([Table II](#tII-mmr-19-05-4364){ref-type="table"}). The age of patients upon diagnosis with FRG via an initial urine test is between 2 months and 82 years. Among the 83 cases for which the sex was identified, the male-to-female ratio was 1.18:1. The mutation states are heterozygous, homozygous and compound heterozygous. In summary, 86 mutations of the *SLC5A2* gene, including one containing the novel mutation p.W172R in the present study, throughout exons 2--14 and the flanking intronic regions, have been reported to be associated with FRG in patients of different ethnicities ([Table III](#tIII-mmr-19-05-4364){ref-type="table"}). The three most common mutation sites are located in exon 11 (16/86=18.60%), exon 8 (11/86=12.79%) and exon 4 (10/86=11.63%). The mutations are primarily missense (65/86=75.58%), frameshift (7/86=8.14%), splicing (5/86=5.81%), and nonsense (4/86=4.65%) mutations. Chinese and Korean patients in the East Asian region account for 44.31% (39/88) of all reported mutations.

Discussion
==========

FRG is an isolated disorder of glucose transport in the proximal tubule with normal glucose metabolism, and may occur in all age groups. The disease has not been reported to occur at any increased frequency in either males or females. The prevalence of FRG has been suggested to be 0.29% in the general Caucasian population ([@b23-mmr-19-05-4364]), while it is suspected to have a prevalence of \<0.1% in Japanese schoolchildren ([@b24-mmr-19-05-4364]). FRG is classified into three types (A, B and O) according to urinary glucose levels ([@b25-mmr-19-05-4364]). Severe FRG (glucosuria ≥10 g/1.73 m^2^/24 h), termed type O FRG, is a rare subtype. Patients with type A FRG are characterized by a low renal threshold for glucose and low maximum tubular glucose reabsorption. Those with type B have a low threshold but normal maximum tubular glucose reabsorption. By contrast, patients with type O have a complete absence of renal glucose transport ([@b25-mmr-19-05-4364]). In the majority of affected individuals, the condition causes no apparent symptoms or serious effects associated with the excessive urinary excretion of glucose, such as polyuria or enuresis. However, polyuria, enuresis and a mild delay in growth are reported in patients with type O FRG ([@b26-mmr-19-05-4364]). Various other manifestations, such as episodic dehydration and starvation ketosis, and an increased incidence of urinary tract or genital infection, have also been observed in cases of severe FRG ([@b25-mmr-19-05-4364]). Collectively, kidney biopsies in patients with FRG indicate normal kidney tissue via light microscopy, immunofluorescence and electron microscopy ([@b14-mmr-19-05-4364]).

As the member of the sodium glucose cotransporter family, SGLT2 is primarily expressed in the kidney and helps to maintain \~90% glomerular filtration during glucose reabsorption ([@b27-mmr-19-05-4364]). The *SLC5A2* gene is localized in chromosome 16p11.2, with 14 exons, and encodes SGLT2, which contains 672 amino acids. Previous studies have revealed that *SLC5A2* mutations are closely associated with the occurrence of FRG ([@b3-mmr-19-05-4364]--[@b22-mmr-19-05-4364]). FRG is primarily caused by mutations in the *SLC5A2* gene, which are responsible for the majority of cases. Regarding inheritance patterns, FRG may be inherited in an autosomal recessive or autosomal dominant pattern. However, studies have demonstrated that the inheritance of FRG may best be described as co-dominant with incomplete penetrance ([@b4-mmr-19-05-4364],[@b22-mmr-19-05-4364]). Previous studies have suggested that patients with heterozygous *SLC5A2* mutations are likely to exhibit mild glucosuria (glucosuria \<10 g/1.73 m^2^/24 h), while homozygous or compound heterozygous mutations tend to lead to severe glucosuria ([@b4-mmr-19-05-4364],[@b8-mmr-19-05-4364],[@b12-mmr-19-05-4364]). Not all individuals with heterozygous *SLC5A2* variants exhibit glucosuria; this highlights the issue of penetrance ([@b28-mmr-19-05-4364]). Penetrance is difficult to determine reliably, even for genetic diseases that are caused by a single polymorphic allele. For many hereditary diseases, the onset of symptoms is age-associated and affected by environmental factors, such as diet and climate, in addition to genetic cofactors and the epigenetic regulation of expression ([@b29-mmr-19-05-4364]). Specifically, a diagnosis of FRG depends on the detection of urine glucose levels, thus it may be missed due to alterations in the urine glucose level. For example, the urine glucose level will be impacted by the amount of sugar consumed recently.

In the present study, two missense mutations in the *SLC5A2* gene of a Chinese patient with FRG accompanied by benign clinical symptoms were reported, one of which was a novel missense mutation (c.514T\>C; p.W172R). A total of two previous studies reported that the p.P514S mutation led to FRG with single heterozygous or compound heterozygous status (p.G77R, p.P514S; p.V477G, p.P514S) ([@b12-mmr-19-05-4364],[@b22-mmr-19-05-4364]). The parents of the proband in the present study carried missense mutations at different locations in terms of *SLC5A2* cDNA position, but neither of them had history of glucosuria. Nevertheless, the patient, with p.W172R and p.P514S missense mutations, exhibited severe glucosuria. It is possible that wild-type SGLT2 may serve a compensatory role during the occurrence of FRG caused by *SLC5A2* mutations. These results indicated that the inheritance patterns of FRG are best described as co-dominant. Therefore, it may be surmised that the p.W172R and p.P514S compound heterozygous mutation of the *SLC5A2* gene contributes to FRG.

SGLT2 has 14 transmembrane helices (TMHs) with the hydrophobic N- and C-terminal domains lying in the extracellular space and contains a sodium solute symporter domain (<http://smart.embl-heidelberg.de/>; TMHMM server V.2.0). An earlier study on the transport mechanisms of the SGLT1/SGLT2 chimera indicated that the C-terminal domain determined sugar affinity and selectivity ([@b30-mmr-19-05-4364]). p.W172 and p.P514 are localized in the extracellular loops between TMH 4 and TMH 5, and between TMH 12 and 13, respectively ([Fig. 4](#f4-mmr-19-05-4364){ref-type="fig"}). p.W172 and p.P514 residues were identified to be highly conserved among numerous other species. Meanwhile, these two mutations were not detected in 100 chromosomes derived from 50 healthy and unrelated individuals, or in the three SNP databases retrieved for this study, indicating that this is not a common polymorphism. Moreover, the pathogenicity prediction based on three online algorithms demonstrated that the mutations p.W172R and p.P514S may be deleterious. A previous *in vitro* functional expression study of *SLC5A2* mutations demonstrated that six missense mutations (c.294C\>A, c.736C\>T, c.1051T\>C, c.1400T\>C, c.1420G\>C and c.1691G\>A) appeared to affect transport activity by reducing intrinsic transporter activity, impairing protein insertion into the cell membrane, suppressing protein synthesis and promoting protein removal or degradation ([@b15-mmr-19-05-4364]). Therefore, it is thought that these two mutation sites may be of particular functional significance in the pathogenesis of FRG. Further *in vitro* research projects on kidney cells involving the construction of specific plasmids are required to confirm the pathogenic nature of these mutations.

According to a review of the literature, 86 mutations in the *SLC5A2* gene have been reported to be associated with FRG. Missense, frameshift and splicing mutations are the most common among these. It is likely that mutations of the *SLC5A2* gene may occur among different demographic groups. Among the 115 patients with FRG considered in the present study, there is no specific age at diagnosis that is most common, nor a significant sex difference. A majority of severe FRG cases exhibit mutation states that are homozygous or compound heterozygous, suggesting that the mode of inheritance may be explained as a co-dominant pattern with incomplete penetrance. It is noteworthy that three FRG patients had no mutations in the *SLC5A2* gene ([@b4-mmr-19-05-4364],[@b9-mmr-19-05-4364]). In addition, not all individuals with similar or identical mutations have the same degree of increased glucose excretion, suggesting a role for non-genetic factors or other genes in glucose transport. Also, other SGLTs that are known to be expressed in the kidney and whose functions have not yet been clarified are candidate modified genes in cases of FRG ([@b4-mmr-19-05-4364],[@b31-mmr-19-05-4364]). In the majority of affected individuals, the condition causes no apparent symptoms or serious effects, such as hypoglycemia, polyuria or dehydration. Therefore, patients with FRG have a good prognosis. Based on this, SGLT2 inhibitors are gradually becoming a promising antihyperglycemic medication with which to improve the prognosis of diabetic kidney disease while maintaining cardiovascular safety, according to a number of clinical trials ([@b32-mmr-19-05-4364]). Thus, understanding the functional significance and pathogenic role of variants in the *SLC5A2* gene is essential.

However, there remain certain limitations to the present study. First, histological analysis of the kidneys in the patient was not performed to verify the expression of SGLT2. Second, since there was only one case included in the present study, it was difficult to acquire abundant information regarding the genotype-phenotype association. Third, further *in vitro* studies are required to confirm the pathogenic variants.

In conclusion, the present study identified a compound heterozygous mutation (p.W172R and p.P514S) of the *SLC5A2* gene in a Chinese patient with FRG. The mechanism whereby the p.W172R and p.P514S mutations impair SGLT2 function, in addition to the exact mechanism of abnormal glucose transport in FRG, requires further investigation.
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![Mutation analysis of the solute carrier family 5 member 2 gene in family members affected with familial renal glucosuria. The positions of the mutations are indicated by the red arrows. (A) The proband harbored a compound heterozygous mutation, c.514T\>C and c.1540C\>T. (B) The father of the proband was an asymptomatic heterozygous mutation c.1540C\>T carrier. (C) The mother of the proband was detected to have an asymptomatic heterozygous mutation c.514T\>C.](MMR-19-05-4364-g00){#f1-mmr-19-05-4364}

![Multiple amino acid sequence alignments of the solute carrier family 5 member 2 gene. The Trp172 and Pro514 residues were highly conserved across various species. The specific position is indicated with a black rectangle.](MMR-19-05-4364-g01){#f2-mmr-19-05-4364}

![Pathogenicity of identified mutations in the solute carrier family 5 member 2 gene predicted by PolyPhen-2. The two missense mutations (c.514T\>C and c.1540C\>T) were both predicted to be 'probably damaging', with a score of (A) 0.991 and (B) 1.000, respectively.](MMR-19-05-4364-g02){#f3-mmr-19-05-4364}

![Schematic diagram of SGLT2. The SGLT2 protein is represented as a 14 transmembrane domain protein with extracellular amino and carboxyl termini. Transmembrane helices 1--14 are illustrated as cylinders. Arabic numerals represent the number of amino acid. The blue lines and cylinders indicate the sodium solute symporter domain. The sites of the mutations (p.W172R and p.P514S) identified in the present study are denoted by arrows. SGLT2, sodium-glucose cotransporter 2.](MMR-19-05-4364-g03){#f4-mmr-19-05-4364}

###### 

Predicted pathogenicity of two missense mutations in the solute carrier family 5 member 2 gene.

  Site     Nucleotide changes   Amino acid change   SIFT          PolyPhen-2          Mutation taster
  -------- -------------------- ------------------- ------------- ------------------- -----------------
  Exon5    c.514T\>C            p.W172R             Deleterious   Probably damaging   Disease causing
  Exon12   c.1540C\>T           p.P514S             Tolerated     Probably damaging   Disease causing

###### 

Literature review of the clinical characteristics and mutational analysis of the solute carrier family 5 member 2 gene in patients with familial renal glucosuria.

  Author, year                                        Age, years^[a](#tfn1-mmr-19-05-4364){ref-type="table-fn"}^   Sex      Urine glucose (g/1.73 m^2^/24 h)                           Allele 1             Allele 2                  Mutation state          (Refs.)
  --------------------------------------------------- ------------------------------------------------------------ -------- ---------------------------------------------------------- -------------------- ------------------------- ----------------------- -------------------------
  van den Heuvel *et al*, 2002                        2                                                            Male     61.6 g/l^[b](#tfn2-mmr-19-05-4364){ref-type="table-fn"}^   c.1320G\>A           c.1320G\>A                Homozygous              ([@b3-mmr-19-05-4364])
  Santer *et al*, 2003                                --                                                           --       126-162.2                                                  c.973-7 del ATGTT    c.973-7 del ATGTT         Homozygous              ([@b4-mmr-19-05-4364])
  Santer *et al*, 2003                                --                                                           --       73.6                                                       c.814G\>A            c.814G\>A                 Homozygous              ([@b4-mmr-19-05-4364])
  Santer *et al*, 2003                                --                                                           --       50.6--51.3                                                 IVS7+5G\>A           IVS7+5G\>A                Homozygous              ([@b4-mmr-19-05-4364])
  Santer *et al*, 2003                                --                                                           --       21.3                                                       IVS7+5G\>A           c.920T\>C                 Compound heterozygous   ([@b4-mmr-19-05-4364])
  Santer *et al*, 2003                                --                                                           --       28.5                                                       IVS7+5G\>A           c.920T\>C                 Compound heterozygous   ([@b4-mmr-19-05-4364])
  Santer *et al*, 2003                                --                                                           --       43.0                                                       c.1346G\>A           c.1346G\>A                Homozygous              ([@b4-mmr-19-05-4364])
  Santer *et al*, 2003                                --                                                           --       68.7                                                       c.1320G\>A           c.1320G\>A                Homozygous              ([@b4-mmr-19-05-4364])
  Santer *et al*, 2003                                --                                                           --       20.8                                                       c.1461-517 del 57    --                        --                      ([@b4-mmr-19-05-4364])
  Santer *et al*, 2003                                --                                                           --       0.6                                                        c.1951-92 del 42     WT                        Heterozygous            ([@b4-mmr-19-05-4364])
  Santer *et al*, 2003                                --                                                           --       38.8                                                       c.1102C\>T           c.1102C\>T                Homozygous              ([@b4-mmr-19-05-4364])
  Santer *et al*, 2003                                --                                                           --       2.3--4.5                                                   c.506delC            WT                        Heterozygous            ([@b4-mmr-19-05-4364])
  Santer *et al*, 2003                                --                                                           --       0.75                                                       IVS7+5G\>A           WT                        Heterozygous            ([@b4-mmr-19-05-4364])
  Santer *et al*, 2003                                --                                                           --       14.6                                                       IVS7+5G\>A           c.932A\>G                 Compound heterozygous   ([@b4-mmr-19-05-4364])
  Santer *et al*, 2003                                --                                                           --       5.9                                                        c.216C\>A            WT                        Heterozygous            ([@b4-mmr-19-05-4364])
  Santer *et al*, 2003                                --                                                           --       2.8                                                        WT                   WT                        --                      ([@b4-mmr-19-05-4364])
  Santer *et al*, 2003                                --                                                           --       202                                                        c.410G\>A            c.1152-63 del 12          Compound heterozygous   ([@b4-mmr-19-05-4364])
  Santer *et al*, 2003                                --                                                           --       79.8                                                       c.410G\>A            c.1152-63 del 12          Compound heterozygous   ([@b4-mmr-19-05-4364])
  Santer *et al*, 2003                                --                                                           --       1.8                                                        c.151A\>C            WT                        Heterozygous            ([@b4-mmr-19-05-4364])
  Santer *et al*, 2003                                --                                                           --       30.1--92.4                                                 c.1627A\>C           c.1627A\>C                Homozygous              ([@b4-mmr-19-05-4364])
  Santer *et al*, 2003                                --                                                           --       4.8                                                        c.313G\>A            WT                        Heterozygous            ([@b4-mmr-19-05-4364])
  Santer *et al*, 2003                                --                                                           --       8.0--16.7                                                  WT                   WT                        --                      ([@b4-mmr-19-05-4364])
  Santer *et al*, 2003                                --                                                           --       31.7                                                       c.448T\>C            c.1495C\>T                Compound heterozygous   ([@b4-mmr-19-05-4364])
  Santer *et al*, 2003                                --                                                           --       1.2                                                        c.1359C\>A           WT                        Heterozygous            ([@b4-mmr-19-05-4364])
  Santer *et al*, 2003                                --                                                           --       1.9                                                        c.1152-63 del 12     WT                        Heterozygous            ([@b4-mmr-19-05-4364])
  Santer *et al*, 2003                                --                                                           --       0.75                                                       IVS7+5G\>A           WT                        Heterozygous            ([@b4-mmr-19-05-4364])
  Calado *et al*, 2004                                41                                                           Male     12                                                         c.500delA            c.1961A\>G                Compound heterozygous   ([@b5-mmr-19-05-4364])
  Kleta *et al*, 2004                                 19                                                           Female   9.1                                                        c.599C\>A            c.1961A\>G                Compound heterozygous   ([@b6-mmr-19-05-4364])
  Francis *et al*, 2004                               82                                                           Female   \>30                                                       c.G910A+G911A        c.G910A+G911A             Homozygous              ([@b7-mmr-19-05-4364])
  Magen *et al*, 2005                                 3                                                            Male     83                                                         c.962A\>G            c.962A\>G                 Homozygous              ([@b8-mmr-19-05-4364])
  Magen *et al*, 2005                                 1.5                                                          Female   101                                                        c.962A\>G            c.962A\>G                 Homozygous              ([@b8-mmr-19-05-4364])
  Magen *et al*, 2005                                 0.2                                                          Male     95                                                         c.962A\>G            c.962A\>G                 Homozygous              ([@b8-mmr-19-05-4364])
  Magen *et al*, 2005                                 0.5                                                          Male     114                                                        c.962A\>G            c.962A\>G                 Homozygous              ([@b8-mmr-19-05-4364])
  Magen *et al*, 2005                                 1                                                            Female   124                                                        c.962A\>G            c.962A\>G                 Homozygous              ([@b8-mmr-19-05-4364])
  Magen *et al*, 2005                                 9                                                            Male     169                                                        c.962A\>G            c.962A\>G                 Homozygous              ([@b8-mmr-19-05-4364])
  Calado *et al*, 2006                                50                                                           --       7.6                                                        c.500delA            WT                        Heterozygous            ([@b9-mmr-19-05-4364])
  Calado *et al*, 2006                                40                                                           --       11.6                                                       IVS12+1G\>A          WT                        Heterozygous            ([@b9-mmr-19-05-4364])
  Calado *et al*, 2006                                8                                                            --       6.4                                                        IVS12+1G\>A          IVS12+1G\>A               Homozygous              ([@b9-mmr-19-05-4364])
  Calado *et al*, 2006                                3                                                            --       12.2                                                       IVS12+1G\>A          IVS12+1G\>A               Homozygous              ([@b9-mmr-19-05-4364])
  Calado *et al*, 2006                                1                                                            --       6.2                                                        c.395G\>A            c.655G\>A                 Compound heterozygous   ([@b9-mmr-19-05-4364])
  Calado *et al*, 2006                                6                                                            --       12.1                                                       WT                   WT                        --                      ([@b9-mmr-19-05-4364])
  Calado *et al*, 2006                                26                                                           --       65.6                                                       c.305C\>T            c.305C\>T                 Homozygous              ([@b9-mmr-19-05-4364])
  Calado *et al*, 2008                                21                                                           Male     3.2                                                        c.346G\>A            WT                        Heterozygous            ([@b10-mmr-19-05-4364])
  Calado *et al*, 2008                                48                                                           Male     6.1                                                        c.1672C\>T           WT                        Heterozygous            ([@b10-mmr-19-05-4364])
  Calado *et al*, 2008                                28                                                           Female   2.7                                                        c.1961A\>G           WT                        Heterozygous            ([@b10-mmr-19-05-4364])
  Calado *et al*, 2008                                6                                                            Male     62.3                                                       IVS7+5G\>A           IVS7+5G\>A                Homozygous              ([@b10-mmr-19-05-4364])
  Calado *et al*, 2008                                24                                                           Female   86.5                                                       c.670G\>C            c.670G\>C                 Homozygous              ([@b10-mmr-19-05-4364])
  Calado *et al*, 2008                                42                                                           Female   30                                                         c.131T\>A            c.1145T\>C                Compound heterozygous   ([@b10-mmr-19-05-4364])
  Calado *et al*, 2008                                14                                                           Female   61.1                                                       c.601G\>A            c.1159C\>A                Compound heterozygous   ([@b10-mmr-19-05-4364])
  Calado *et al*, 2008                                33                                                           Male     n.q.                                                       c.968C\>G            c.1961A\>G                Compound heterozygous   ([@b10-mmr-19-05-4364])
  Calado *et al*, 2008                                1.5                                                          Male     35.5                                                       c.1102C\>T           c.1359C\>A                Compound heterozygous   ([@b10-mmr-19-05-4364])
  Calado *et al*, 2008                                8                                                            Female   n.q.                                                       IVS7+5G\>A           c.1428C\>G                Compound heterozygous   ([@b10-mmr-19-05-4364])
  Calado *et al*, 2008                                66                                                           Female   10                                                         c.1446G\>C           c.1961A\>G                Compound heterozygous   ([@b10-mmr-19-05-4364])
  Calado *et al*, 2008                                16                                                           Female   6.5                                                        c.898C\>T            WT                        Heterozygous            ([@b10-mmr-19-05-4364])
  Calado *et al*, 2008                                8                                                            Male     n.q.                                                       IVS7+5G\>A           IVS7+5G\>A                Homozygous              ([@b10-mmr-19-05-4364])
  Calado *et al*, 2008                                5                                                            Female   n.q.                                                       IVS7+5G\>A           IVS7+5G\>A                Homozygous              ([@b10-mmr-19-05-4364])
  Calado *et al*, 2008                                12                                                           Male     15.2                                                       c.1616T\>C           c.1616T\>C                Homozygous              ([@b10-mmr-19-05-4364])
  Calado *et al*, 2008                                9                                                            Male     23.1                                                       c.1616T\>C           c.1616T\>C                Homozygous              ([@b10-mmr-19-05-4364])
  Calado *et al*, 2008                                2                                                            Female   14.2                                                       IVS7+5G\>A           c.1405G\>A                Compound heterozygous   ([@b10-mmr-19-05-4364])
  Calado *et al*, 2008                                16                                                           Female   66.9                                                       c.1068G\>A           IVS12+1G\>A               Compound heterozygous   ([@b10-mmr-19-05-4364])
  Calado *et al*, 2008                                12                                                           Female   72.7                                                       c.384C\>G            c.384C\>G                 Homozygous              ([@b10-mmr-19-05-4364])
  Yu *et al*, 2011                                    36                                                           Female   16.06                                                      IVS11+1G\>C          IVS1-16C\>A               Compound heterozygous   ([@b11-mmr-19-05-4364])
  Yu *et al*, 2011                                    27                                                           Male     6.47                                                       c.294C\>A            WT                        Heterozygous            ([@b11-mmr-19-05-4364])
  Yu *et al*, 2011                                    41                                                           Female   6.30                                                       c.1388T\>G           WT                        Heterozygous            ([@b11-mmr-19-05-4364])
  Yu *et al*, 2011                                    15                                                           Female   27                                                         IVS1-16C\>A          c.1435C\>G                Compound heterozygous   ([@b11-mmr-19-05-4364])
  Lee *et al*, 2012                                   --                                                           Male     46.6^[c](#tfn3-mmr-19-05-4364){ref-type="table-fn"}^       c.1435C\>G,          c.1346G\>A                Compound heterozygous   ([@b12-mmr-19-05-4364])
  Lee *et al*, 2012                                   --                                                           Male     18.3^[c](#tfn3-mmr-19-05-4364){ref-type="table-fn"}^       c.979C\>T            c.1499T\>G                Compound heterozygous   ([@b12-mmr-19-05-4364])
  Lee *et al*, 2012                                   --                                                           Male     25.9^[c](#tfn3-mmr-19-05-4364){ref-type="table-fn"}^       c.1540C\>T           c.1430T\>G                Compound heterozygous   ([@b12-mmr-19-05-4364])
  Lee *et al*, 2012                                   --                                                           Male     67.8^[c](#tfn3-mmr-19-05-4364){ref-type="table-fn"}^       c.409C\>T            c.1732C\>T                Compound heterozygous   ([@b12-mmr-19-05-4364])
  Lee *et al*, 2012                                   --                                                           Male     39.7^[c](#tfn3-mmr-19-05-4364){ref-type="table-fn"}^       c.1346G\>A           c.1540C\>T                Compound heterozygous   ([@b12-mmr-19-05-4364])
  Lee *et al*, 2012                                   --                                                           Female   22.0^[c](#tfn3-mmr-19-05-4364){ref-type="table-fn"}^       c.736C\>T            c.1499T\>G                Compound heterozygous   ([@b12-mmr-19-05-4364])
  Lee *et al*, 2012                                   --                                                           Male     15.3^[c](#tfn3-mmr-19-05-4364){ref-type="table-fn"}^       c.1346G\>A           c.1346G\>A                Homozygous              ([@b12-mmr-19-05-4364])
  Lee *et al*, 2012                                   --                                                           Female   76.8^[c](#tfn3-mmr-19-05-4364){ref-type="table-fn"}^       c.409C\>T            c.1475_1476insC           Compound heterozygous   ([@b12-mmr-19-05-4364])
  Lee *et al*, 2012                                   --                                                           Male     32.7^[c](#tfn3-mmr-19-05-4364){ref-type="table-fn"}^       c.983T\>G            c.1894_1895ins6           Compound heterozygous   ([@b12-mmr-19-05-4364])
  Lee *et al*, 2012                                   --                                                           Male     42.6^[c](#tfn3-mmr-19-05-4364){ref-type="table-fn"}^       c.1382G\>A           c.1540C\>T                Compound heterozygous   ([@b12-mmr-19-05-4364])
  Lee *et al*, 2012                                   --                                                           Male     24.9^[c](#tfn3-mmr-19-05-4364){ref-type="table-fn"}^       c.1346G\>A           WT                        Heterozygous            ([@b12-mmr-19-05-4364])
  Lee *et al*, 2012                                   --                                                           Male     12.1^[c](#tfn3-mmr-19-05-4364){ref-type="table-fn"}^       c.867G\>C            WT                        Heterozygous            ([@b12-mmr-19-05-4364])
  Lee *et al*, 2012                                   --                                                           Female   35.2^[c](#tfn3-mmr-19-05-4364){ref-type="table-fn"}^       c.1346G\>A           WT                        Heterozygous            ([@b12-mmr-19-05-4364])
  Lee *et al*, 2012                                   --                                                           Male     30.9^[c](#tfn3-mmr-19-05-4364){ref-type="table-fn"}^       c.1798delC           WT                        Heterozygous            ([@b12-mmr-19-05-4364])
  Lee *et al*, 2012                                   --                                                           Female   8.9^[c](#tfn3-mmr-19-05-4364){ref-type="table-fn"}^        c.320T\>C            WT                        Heterozygous            ([@b12-mmr-19-05-4364])
  Lee *et al*, 2012                                   --                                                           Male     33.7^[c](#tfn3-mmr-19-05-4364){ref-type="table-fn"}^       c.938G\>A            WT                        Heterozygous            ([@b12-mmr-19-05-4364])
  Lee *et al*, 2012                                   --                                                           Male     16.2^[c](#tfn3-mmr-19-05-4364){ref-type="table-fn"}^       c.1346G\>A           WT                        Heterozygous            ([@b12-mmr-19-05-4364])
  Lee *et al*, 2012                                   --                                                           Male     6.9^[c](#tfn3-mmr-19-05-4364){ref-type="table-fn"}^        c.1507G\>A           WT                        Heterozygous            ([@b12-mmr-19-05-4364])
  Lee *et al*, 2012                                   --                                                           Female   5.1^[c](#tfn3-mmr-19-05-4364){ref-type="table-fn"}^        c.1540C\>T           WT                        Heterozygous            ([@b12-mmr-19-05-4364])
  Lee *et al*, 2012                                   --                                                           Male     25.2^[c](#tfn3-mmr-19-05-4364){ref-type="table-fn"}^       c.1418_1432dup15     WT                        Heterozygous            ([@b12-mmr-19-05-4364])
  Lee *et al*, 2012                                   --                                                           Female   1.9^[c](#tfn3-mmr-19-05-4364){ref-type="table-fn"}^        c.1357T\>A           WT                        Heterozygous            ([@b12-mmr-19-05-4364])
  Lee *et al*, 2012                                   --                                                           Female   15.5^[c](#tfn3-mmr-19-05-4364){ref-type="table-fn"}^       c.1346G\>A           WT                        Heterozygous            ([@b12-mmr-19-05-4364])
  Lee *et al*, 2012                                   --                                                           Male     4.7^[c](#tfn3-mmr-19-05-4364){ref-type="table-fn"}^        c.170T\>C            WT                        Heterozygous            ([@b12-mmr-19-05-4364])
  Lee, 2013                                           40                                                           Male     10.8                                                       c.1162delG           WT                        Heterozygous            ([@b13-mmr-19-05-4364])
  Yu *et al*, 2014                                    50                                                           Male     4.8                                                        c.229G\>C            WT                        Heterozygous            ([@b14-mmr-19-05-4364])
  Lee, 2013                                           40                                                           Male     10.8                                                       c.1162delG           WT                        Heterozygous            ([@b13-mmr-19-05-4364])
  Yu *et al*, 2015                                    36                                                           Female   12.9                                                       c.294C\>A            WT                        Heterozygous            ([@b15-mmr-19-05-4364])
  Yu *et al*, 2015                                    27                                                           Male     19.6                                                       c.736C\>T            c.1420G\>C                Compound heterozygous   ([@b15-mmr-19-05-4364])
  Yu *et al*, 2015                                    20                                                           Male     5.9                                                        c.1051T\>C           WT                        Heterozygous            ([@b15-mmr-19-05-4364])
  Yu *et al*, 2015                                    58                                                           Male     7.3                                                        c.1400T\>C           WT                        Heterozygous            ([@b15-mmr-19-05-4364])
  Yu *et al*, 2015                                    61                                                           Male     8.1                                                        c.1691G\>A           WT                        Heterozygous            ([@b15-mmr-19-05-4364])
  Dhayat *et al*, 2016                                70.3                                                         Female   6.71                                                       c.265G\>A            WT                        Heterozygous            ([@b16-mmr-19-05-4364])
  Dhayat *et al*, 2016                                65.3                                                         Female   11.77                                                      c.265G\>A            WT                        Heterozygous            ([@b16-mmr-19-05-4364])
  Dhayat *et al*, 2016                                61.8                                                         Female   5.54                                                       c.265G\>A            WT                        Heterozygous            ([@b16-mmr-19-05-4364])
  Dhayat *et al*, 2016                                40.2                                                         Female   6.53                                                       c.265G\>A            WT                        Heterozygous            ([@b16-mmr-19-05-4364])
  Dhayat *et al*, 2016                                27.1                                                         Male     1.10                                                       c.265G\>A            WT                        Heterozygous            ([@b16-mmr-19-05-4364])
  Ottosson-Laakso *et al*, 2016                       --                                                           Female   55.2                                                       c.300-303+2del       --                        Compound heterozygous   ([@b17-mmr-19-05-4364])
  Yu *et al*, 2016                                    39                                                           Female   7.56                                                       c.1891G\>A           WT                        Heterozygous            ([@b18-mmr-19-05-4364])
  Yu *et al*, 2016                                    36                                                           Female   8.3                                                        c.1319G\>A           WT                        Heterozygous            ([@b19-mmr-19-05-4364])
  Zhao *et al*, 2016                                  22                                                           Male     10.56                                                      c.1003A\>G           c.1343A\>G + c.1739G\>A   Compound heterozygous   ([@b20-mmr-19-05-4364])
  Zhao *et al*, 2016                                  26                                                           Male     1.96                                                       c.886(−10\_-31)del   WT                        Heterozygous            ([@b20-mmr-19-05-4364])
  Zhao *et al*, 2016                                  30                                                           Male     1.77                                                       c.886(−10\_-31)del   WT                        Heterozygous            ([@b20-mmr-19-05-4364])
  Zhao *et al*, 2016                                  32                                                           Female   1.66                                                       c.886(−10\_-31)del   WT                        Heterozygous            ([@b20-mmr-19-05-4364])
  Zhao *et al*, 2016                                  25                                                           Male     12.74                                                      c.886(−10\_-31)del   WT                        Heterozygous            ([@b20-mmr-19-05-4364])
  Zhao *et al*, 2016                                  52                                                           Male     1.34                                                       c.1420G\>C           WT                        Heterozygous            ([@b20-mmr-19-05-4364])
  Zhao *et al*, 2016                                  38                                                           Male     50.68                                                      c.886(−10\_-31)del   c.886(−10\_-31)del        Compound heterozygous   ([@b20-mmr-19-05-4364])
  Zhao *et al*, 2016                                  48                                                           Female   1.78                                                       c.393G\>C            WT                        Heterozygous            ([@b20-mmr-19-05-4364])
  Kim *et al*, 2016                                   26                                                           Male     3.7                                                        c.395G\>A            WT                        Heterozygous            ([@b21-mmr-19-05-4364])
  Wang *et al*, 2017                                  24                                                           Female   8.06                                                       c.877A\>T            WT                        Heterozygous            ([@b22-mmr-19-05-4364])
  Wang *et al*, 2017                                  4                                                            Female   10.96                                                      c.229G\>C            c.1540C\>T                Compound heterozygous   ([@b22-mmr-19-05-4364])
  −^[d](#tfn4-mmr-19-05-4364){ref-type="table-fn"}^   1.75                                                         Female   15.77                                                      c.514T\>C            c.1540C\>T                Compound heterozygous   --

At the time of evaluation

the level of urine glucose was only available in g/l

spot urine glucose/creatinine ratio (mg/mg)

the present study. WT, wild type; n.q., persistent glucosuria not quantified.

###### 

Literature review of solute carrier family 5 member 2 gene mutations of patients with familial renal glucosuria.

  Author, year                                  Site        Ethnicity                                                                           Nucleotide change    Amino acid change          Mutation type   (Refs.)
  --------------------------------------------- ----------- ----------------------------------------------------------------------------------- -------------------- -------------------------- --------------- -----------------------------------------------------------------------------------------------
  Yu *et al*, 2011                              Intron 1    Chinese                                                                             IVS1-16C\>A          --                         Splicing        ([@b11-mmr-19-05-4364])
  Calado *et al*, 2008                          Exon 2      American                                                                            c.131T\>A            p.M44K                     Missense        ([@b10-mmr-19-05-4364])
  Santer *et al*, 2003                          Exon 2      NA                                                                                  c.151A\>C            p.T51P                     Missense        ([@b4-mmr-19-05-4364])
  Lee *et al*, 2012                             Exon 2      Korean                                                                              c.170T\>C            p.L57P                     Missense        ([@b12-mmr-19-05-4364])
  Santer *et al*, 2003                          Exon 3      NA                                                                                  c.216C\>A            p.F72L                     Missense        ([@b4-mmr-19-05-4364])
  Yu *et al*, 2014; Wang *et al*, 2017          Exon 3      Chinese                                                                             c.229G\>C            p.G77R                     Missense        ([@b14-mmr-19-05-4364],[@b22-mmr-19-05-4364])
  Dhayat *et al*, 2016                          Exon 3      Swiss                                                                               c.265G\>A            p.A89T                     Missense        ([@b16-mmr-19-05-4364])
  Yu *et al*, 2011; Yu *et al*, 2015            Exon 3      Chinese                                                                             c.294C\>A            p.F98L                     Missense        ([@b11-mmr-19-05-4364],[@b15-mmr-19-05-4364])
  Laakso *et al*, 2016                          Exon 3      Finnish                                                                             c.300-303+2del       --                         Frameshift      ([@b17-mmr-19-05-4364])
  Calado *et al*, 2006                          Exon 4      Turkish                                                                             c.305C\>T            p.A102V                    Missense        ([@b9-mmr-19-05-4364])
  Santer *et al*, 2003                          Exon 4      NA                                                                                  c.313G\>A            p.V105M                    Missense        ([@b4-mmr-19-05-4364])
  Lee *et al*, 2012                             Exon 4      Korean                                                                              c.320T\>C            p.L107P                    Missense        ([@b12-mmr-19-05-4364])
  Calado *et al*, 2008                          Exon 4      Portuguese                                                                          c.346G\>A            p.V116M                    Missense        ([@b10-mmr-19-05-4364])
  Calado *et al*, 2008                          Exon 4      Turkish                                                                             c.384C\>G            p.Y128X                    Nonsense        ([@b10-mmr-19-05-4364])
  Zhao *et al*, 2016                            Exon 4      Chinese                                                                             c.393G\>C            p.K131N                    Missense        ([@b20-mmr-19-05-4364])
  Calado *et al*, 2006; Kim *et al*, 2016       Exon 4      Korean, Turkish                                                                     c.395G\>A            p.R132H                    Missense        ([@b9-mmr-19-05-4364],[@b21-mmr-19-05-4364])
  Lee *et al*, 2012                             Exon 4      Korean                                                                              c.409C\>T            p.R137C                    Missense        ([@b12-mmr-19-05-4364])
  Santer *et al*, 2003                          Exon 4      German                                                                              c.410G\>A            p.R137H                    Missense        ([@b4-mmr-19-05-4364])
  Santer *et al*, 2003                          Exon 4      NA                                                                                  c.448T\>C            p.Y150H                    Missense        ([@b4-mmr-19-05-4364])
  Santer *et al*, 2003; Calado *et al*, 2004;   Exon 5      Portuguese, NA                                                                      c.500delA            p.Q167fsX186               Frameshift      ([@b4-mmr-19-05-4364],[@b5-mmr-19-05-4364],[@b9-mmr-19-05-4364])
  Calado *et al*, 2006                                                                                                                                                                                          
  Santer *et al*, 2003                          Exon 5      NA                                                                                  c.506delC            p.Q168fs...186X            Frameshift      ([@b4-mmr-19-05-4364])
                                                Exon 5      Chinese                                                                             c.514T\>C            p.W172R                    Missense        −^[a](#tfn5-mmr-19-05-4364){ref-type="table-fn"}^
  Kleta *et al*, 2004                           Exon 6      Russian/Cuban/Spanish ancestry                                                      c.599C\>A            p.T200K                    Missense        ([@b6-mmr-19-05-4364])
  Calado *et al*, 2008                          Exon 6      Belgian                                                                             c.601G\>A            p.D201N                    Missense        ([@b10-mmr-19-05-4364])
  Calado *et al*, 2006                          Exon 6      Turkish                                                                             c.655G\>A            p.A219T                    Missense        ([@b9-mmr-19-05-4364])
  Calado *et al*, 2008                          Exon 7      Belgian                                                                             c.670G\>C            p.G224R                    Missense        ([@b10-mmr-19-05-4364])
  Lee *et al*, 2012; Yu *et al*, 2015           Exon 7      Korean, Chinese                                                                     c.736C\>T            p.P246S                    Missense        ([@b12-mmr-19-05-4364],[@b15-mmr-19-05-4364])
  Santer *et al*, 2003                          Exon 7      NA                                                                                  c.814G\>A            p.G272R                    Missense        ([@b4-mmr-19-05-4364])
  Lee *et al*, 2012                             Exon 7      Korean                                                                              c.867G\>C            p.W289C                    Missense        ([@b12-mmr-19-05-4364])
  Wang *et al*, 2017                            Exon 7      Chinese                                                                             c.877A\>T            p.S293C                    Missense        ([@b22-mmr-19-05-4364])
  Santer *et al*, 2003; Calado *et al*, 2008    Intron 7    Pakistani, former Yugoslav, Italian, Swiss, Canadian, German, Turkish, Macedonian   IVS7+5G\>A           --                         Splicing        ([@b4-mmr-19-05-4364],[@b10-mmr-19-05-4364])
  Zhao *et al*, 2016                            Intron 7    Chinese                                                                             c.886(−10\_-31)del   --                         Splicing        ([@b20-mmr-19-05-4364])
  Calado *et al*, 2008                          Exon 8      German                                                                              c.898C\>T            p.R300C                    Missense        ([@b10-mmr-19-05-4364])
  Francis *et al*, 2004                         Exon 8      Italian                                                                             c.G910A+G911A        p.G304K                    Missense        ([@b7-mmr-19-05-4364])
  Santer *et al*, 2003                          Exon 8      NA                                                                                  c.920T\>C            p.L307P                    Missense        ([@b4-mmr-19-05-4364])
  Santer *et al*, 2003                          Exon 8      NA                                                                                  c.932A\>G            p.K311R                    Missense        ([@b4-mmr-19-05-4364])
  Lee *et al*, 2012                             Exon 8      Korean                                                                              c.938G\>A            p.G313D                    Missense        ([@b12-mmr-19-05-4364])
  Magen *et al*, 2005                           Exon 8      Israeli-Arab descent                                                                c.962A\>G            p.K321R                    Missense        ([@b8-mmr-19-05-4364])
  Calado *et al*, 2008                          Exon 8      Belgian                                                                             c.968C\>G            p.T323R                    Missense        ([@b10-mmr-19-05-4364])
  Santer *et al*, 2003                          Exon 8      German                                                                              c.973-7 del ATGTT    p.P324fs...347X            Frameshift      ([@b4-mmr-19-05-4364])
  Lee *et al*, 2012                             Exon 8      Korean                                                                              c.979C\>T            p.L327F                    Missense        ([@b12-mmr-19-05-4364])
  Lee *et al*, 2012                             Exon 8      Korean                                                                              c.983T\>G            p.M328R                    Missense        ([@b12-mmr-19-05-4364])
  Zhao *et al*, 2016                            Exon 8      Chinese                                                                             c.1003A\>G           p.S335G                    Missense        ([@b20-mmr-19-05-4364])
  Laakso *et al*, 2016                          Exon 9      Finnish                                                                                                  p.A343V                    Missense        ([@b17-mmr-19-05-4364])
  Yu *et al*, 2015                              Exon 9      Chinese                                                                             c.1051T\>C           p.C351R                    Missense        ([@b15-mmr-19-05-4364])
  Calado *et al*, 2008                          Exon 9      Macedonian                                                                          c.1068G\>A           p.G356S                    Missense        ([@b10-mmr-19-05-4364])
  Santer *et al*, 2003; Calado *et al*, 2008    Exon 9      NA, Greek                                                                           c.1102C\>T           p.R368W                    Missense        ([@b4-mmr-19-05-4364],[@b10-mmr-19-05-4364])
  Calado *et al*, 2008                          Exon 10     American                                                                            c.1145T\>C           p.M382T                    Missense        ([@b10-mmr-19-05-4364])
  Calado *et al*, 2008                          Exon 10     Brazilian                                                                           c.1159C\>A           p.L387M                    Missense        ([@b10-mmr-19-05-4364])
  Lee *et al*, 2013                             Exon 10     Korean                                                                              c.1162delG           p.A388PfsX48               Frameshift      ([@b13-mmr-19-05-4364])
  Santer *et al*, 2003                          Exon 10     German                                                                              c.1152-63 del 12     Δ385-8                     Deletion        ([@b4-mmr-19-05-4364])
  Yu *et al*, 2016                              Exon 11     Chinese                                                                             c.1319G\>A           p.W440X                    Nonsense        ([@b19-mmr-19-05-4364])
  van den Heuvel *et al*, 2002;                 Exon 11     Chinese, Turkish                                                                    c.1320G\>A           p.W440X                    Nonsense        ([@b3-mmr-19-05-4364],[@b4-mmr-19-05-4364],[@b19-mmr-19-05-4364])
  Santer *et al*, 2003; Yu *et al*, 2016                                                                                                                                                                        
  Zhao *et al*, 2016                            Exon 11     Chinese                                                                             c.1343A\>G           p.Q448R                    Missense        ([@b20-mmr-19-05-4364])
  Santer *et al*, 2003; Lee *et al*, 2012       Exon 11     Korean, NA                                                                          c.1346G\>A           p.G449D                    Missense        ([@b4-mmr-19-05-4364],[@b12-mmr-19-05-4364])
  Lee *et al*, 2012                             Exon 11     Korean                                                                              c.1357T\>A           p.F453I                    Missense        ([@b12-mmr-19-05-4364])
  Santer *et al*, 2003; Calado *et al*, 2008    Exon 11     NA, Greek                                                                           c.1359C\>A           p.F453L                    Missense        ([@b4-mmr-19-05-4364],[@b10-mmr-19-05-4364])
  Lee *et al*, 2012                             Exon 11     Korean                                                                              c.1382G\>A           p.S461N                    Missense        ([@b12-mmr-19-05-4364])
  Yu *et al*, 2011                              Exon 11     Chinese                                                                             c.1388T\>G           p.L463R                    Missense        ([@b11-mmr-19-05-4364])
  Yu *et al*, 2015                              Exon 11     Chinese                                                                             c.1400T\>C           p.V467A                    Missense        ([@b15-mmr-19-05-4364])
  Calado *et al*, 2008                          Exon 11     Macedonian                                                                          c.1405G\>A           p.A469T                    Missense        ([@b10-mmr-19-05-4364])
  Lee *et al*, 2012                             Exon 11     Korean                                                                              c.1418_1432dup15     p.473_477dupLALFV          Duplication     ([@b12-mmr-19-05-4364])
  Yu *et al*, 2015; Zhao *et al*, 2016          Exon 11     Chinese                                                                             c.1420G\>C           p.A474P                    Missense        ([@b15-mmr-19-05-4364],[@b20-mmr-19-05-4364])
  Calado *et al*, 2008                          Exon 11     German                                                                              c.1428C\>G           p.F476L                    Missense        ([@b10-mmr-19-05-4364])
  Lee *et al*, 2012                             Exon 11     Korean                                                                              c.1430T\>G           p.V477G                    Missense        ([@b12-mmr-19-05-4364])
  Yu *et al*, 2011; Lee *et al*, 2012           Exon 11     Chinese, Korean                                                                     c.1435C\>G           p.R479G                    Missense        ([@b11-mmr-19-05-4364],[@b12-mmr-19-05-4364])
  Calado *et al*, 2008                          Exon 11     Swiss                                                                               c.1446G\>C           p.E482D                    Missense        ([@b10-mmr-19-05-4364])
  Yu *et al*, 2011                              Intron 11   Chinese                                                                             IVS11+1G\>C          --                         Splicing        ([@b11-mmr-19-05-4364])
  Santer *et al*, 2003                          Exon 12     NA                                                                                  c.1461-517 del 57    p.W487, Δ488-506           Deletion        ([@b4-mmr-19-05-4364])
  Lee *et al*, 2012                             Exon 12     Korean                                                                              c.1475_1476insC      p.L493Pfs\*74              Frameshift      ([@b12-mmr-19-05-4364])
  Santer *et al*, 2003                          Exon 12     NA                                                                                  c.1495C\>T           p.R499C                    missense        ([@b4-mmr-19-05-4364])
  Lee *et al*, 2012                             Exon 12     Korean                                                                              c.1499T\>G           p.L500R                    Missense        ([@b12-mmr-19-05-4364])
  Lee *et al*, 2012                             Exon 12     Korean                                                                              c.1507G\>A           p.E503K                    Missense        ([@b12-mmr-19-05-4364])
  Lee *et al*, 2012; Wang *et al*, 2017         Exon 12     Korean, Chinese                                                                     c.1540C\>T           p.P514S                    Missense        ([@b12-mmr-19-05-4364],[@b22-mmr-19-05-4364])^[a](#tfn5-mmr-19-05-4364){ref-type="table-fn"}^
  Calado *et al*, 2008                          Exon 12     Romanian                                                                            c.1616T\>C           p.L539P                    Missense        ([@b10-mmr-19-05-4364])
  Santer *et al*, 2003                          Exon 12     NA                                                                                  c.1627A\>C           p.T543P                    Missense        ([@b4-mmr-19-05-4364])
  Calado *et al*, 2006; Calado *et al*, 2008    Intron 12   Turkish, Macedonian                                                                 IVS12+1G\>A          --                         Splicing        ([@b9-mmr-19-05-4364],[@b10-mmr-19-05-4364])
  Calado *et al*, 2008                          Exon 13     Portuguese                                                                          c.1672C\>T           p.R558C                    Missense        ([@b10-mmr-19-05-4364])
  Yu *et al*, 2015                              Exon 13     Chinese                                                                             c.1691G\>A           p.R564Q                    Missense        ([@b15-mmr-19-05-4364])
  Lee *et al*, 2012                             Exon 13     Korean                                                                              c.1732C\>T           p.Q578\*                   Nonsense        ([@b12-mmr-19-05-4364])
  Zhao *et al*, 2016                            Exon 13     Chinese                                                                             c.1739G\>A           p.G580D                    Missense        ([@b20-mmr-19-05-4364])
  Lee *et al*, 2012                             Exon 14     Korean                                                                              c.1798delC           p.Q600Rfs\*18              Frameshift      ([@b12-mmr-19-05-4364])
  Yu *et al*, 2016                              Exon 14     Chinese                                                                             c.1891G\>A           p.E631K                    Missense        ([@b18-mmr-19-05-4364])
  Lee *et al*, 2012                             Exon 14     Korean                                                                              c.1894_1895ins6      p.\[A634E; 634_635ins2\]   Insertion       ([@b12-mmr-19-05-4364])
  Santer *et al*, 2003                          Exon 14     NA                                                                                  c.1951-92 del 42     Δ651-64                    Deletion        ([@b4-mmr-19-05-4364])
  Calado *et al*, 2004; Kleta *et al*, 2004;    Exon 14     Portuguese, Belgian, Swiss,                                                         c.1961A\>G           p.N654S                    Missense        ([@b5-mmr-19-05-4364],[@b6-mmr-19-05-4364],[@b10-mmr-19-05-4364])
  Calado *et al*, 2008                                      Russian/Cuban/Spanish ancestry                                                                                                                      

The present study. NA, not available; the patients were from Germany, Switzerland, England, Italy, former Yugoslavia, Turkey or Pakistan, but their countries of origin were not indicated clearly in the article. FRG, familial renal glucosuria.
